184 related articles for article (PubMed ID: 27274165)
1. Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation.
Huang SY; Chen YA; Chen SA; Chen YJ; Lin YK
Acta Cardiol Sin; 2016 May; 32(3):259-64. PubMed ID: 27274165
[TBL] [Abstract][Full Text] [Related]
2. Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications.
Yamagami F; Tajiri K; Yumino D; Ieda M
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614923
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
4. Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: continued search to configure the genuine etiology of "eternal arrhythmia".
Stirbys P
J Atr Fibrillation; 2016 Dec; 9(4):1503. PubMed ID: 29250260
[TBL] [Abstract][Full Text] [Related]
5. [Morphological remodeling in atrial fibrillation].
Goette A; Lendeckel U
Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological approaches in the treatment of atrial fibrillation.
Tamargo J; Caballero R; Delpón E
Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.
Korantzopoulos P; Kolettis T; Siogas K; Goudevenos J
Med Sci Monit; 2003 Sep; 9(9):RA225-9. PubMed ID: 12960937
[TBL] [Abstract][Full Text] [Related]
8. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
9. Electrical, contractile and structural remodeling during atrial fibrillation.
Allessie M; Ausma J; Schotten U
Cardiovasc Res; 2002 May; 54(2):230-46. PubMed ID: 12062329
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases.
Rysz J; Franczyk B; Ławiński J; Gluba-Brzózka A
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33153174
[TBL] [Abstract][Full Text] [Related]
12. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
13. The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis.
Chen WT; Chen YC; Hsieh MH; Huang SY; Kao YH; Chen YA; Lin YK; Chen SA; Chen YJ
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):203-10. PubMed ID: 25244538
[TBL] [Abstract][Full Text] [Related]
14. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
Elahi MM; Flatman S; Matata BM
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation: recent advances in understanding the role of microRNAs in atrial remodeling with an electrophysiological overview.
Poudel P; Xu Y; Cui Z; Sharma D; Tian B; Paudel S
Cardiology; 2015; 131(1):58-67. PubMed ID: 25871909
[TBL] [Abstract][Full Text] [Related]
16. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
17. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
[TBL] [Abstract][Full Text] [Related]
18. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation.
Ren X; Wang X; Yuan M; Tian C; Li H; Yang X; Li X; Li Y; Yang Y; Liu N; Shang H; Gao Y; Xing Y
Curr Pharm Des; 2018; 24(26):3062-3071. PubMed ID: 30179130
[TBL] [Abstract][Full Text] [Related]
20. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors.
Sciacqua A; Perticone M; Tripepi G; Miceli S; Tassone EJ; Grillo N; Carullo G; Sesti G; Perticone F
Int J Cardiol; 2014 Jul; 175(1):90-5. PubMed ID: 24836687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
